Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Current Drug Targets|January 29, 2008
The immune system and murine atherosclerosisGodfrey S Getz, Paul A Vanderlaan, Catherine A Reardon
Arteriosclerosis, Thrombosis, and Vascular Biology|November 8, 2003
Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulatorsPaul A VanderLaan, Catherine A Reardon, Godfrey S Getz
Cancer Cytopathology|February 15, 2023
Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillanceElizabeth A Hall, Pamela Hartzband, Paul A VanderLaan, et al.
Cancer Cytopathology|April 25, 2014
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): an overview and update for the cytopathologistPaul A VanderLaan, Helen H Wang, Adnan Majid, et al.
Translational Lung Cancer Research|September 18, 2015
Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysisErik Folch, Daniel B Costa, Jeffrey Wright, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 17, 2013
A microthymoma and no germinal centre in myasthenia gravisMasatsugu Hamaji, Paul A Vanderlaan, David J Sugarbaker, et al.
Diagnostic Cytopathology|February 24, 2024
Gastrointestinal stromal tumors in fine-needle aspiration biopsiesSeyedreza Mousavi, Yuho Ono, Paul A VanderLaan, et al.
Acta Cytologica|December 14, 2011
Repeatedly nondiagnostic thyroid fine-needle aspirations do not modify malignancy riskVickie Y Jo, Paul A Vanderlaan, Ellen Marqusee, et al.
Cancer Cytopathology|August 29, 2024
Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology-proven malignant pleural effusionsCristiana M Pineda, Adnan Majid, Daniel B Costa, et al.
Cancer Cytopathology|September 16, 2011
The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio: a proposed performance measure for reporting in The Bethesda System for thyroid cytopathologyJeffrey F Krane, Paul A Vanderlaan, William C Faquin, et al.
Pageof 13